Phenotypic modulation of smooth muscle cells is closely associated with vasculogenesis, enterogenesis and some diseases such as atherosclerosis, hypertension and leiomyogenic tumorigenicity. During phenotypic modulation, smooth muscle cells change their morphology, cell function and biochemical characteristics. Recent studies have focused on the regulation mechanism of smooth muscle cell-specific genes at the levels of transcription and/or alternative splicing in a phenotype-dependent manner. Typical examples of such genes include caldesmon, α-tropomyosin, myosin heavy chain, SM22, calponin and α1 integrin. Cell adhesion molecules and growth factors/cytokines also play a critical role for controlling phenotype of smooth muscle cells via signal transduction pathways such as phosphoinositide 3-kinase and mitogen-activated protein kinases.

Keywords:
Smooth muscle, Phenotypic modulation, Caldesmon, Gene expression, Splicing, Contractile protein, α-Smooth muscle actin, SM22, Myosin heavy chain, α1 Integrin
1.
Risau W: Mechanisms of angiogenesis. Nature 1997;386:671–674.
2.
Folkman J, D’Amore PA: Blood vessel formation: What is its molecular basis? Cell 1996;87:1153–1155.
3.
Small JV: The contractile apparatus of the smooth muscle cell: Structure and composition; in Stephens NL (ed): The Biochemistry of Smooth Muscle. Baltimore, University Park Press, 1977, pp 379–411.
4.
Carey DJ: Control of growth and differentiation of vascular cells by extracellular matrix proteins. Annu Rev Physiol 1991;53:161–177.
5.
Risau W, Lemmon V: Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 1998;125:441–450.
6.
North AJ, Galazkiewicz B, Byers TJ, Glenney JR Jr, Small JV: Complementary distributions of vinculin and dystrophin define two distinct sarcolemma domains in smooth muscle. J Cell Biol 1993;120:1159–1167.
7.
Draeger A, Stelzer EH, Herzog M, Small JV: Unique geometry of actin-membrane anchorage sites in avian gizzard smooth muscle cells. J Cell Sci 1989;94:703–711.
8.
Sellers JR, Adelstein RS: The mechanism of regulation of smooth muscle myosin by phosphorylation. Curr Top Cell Regul 1985;27:51–62.
9.
Sobue K, Sellers JR: Caldesmon, a novel regulatory protein in smooth muscle and nonmuscle actomyosin systems. J Biol Chem 1991;266:12115–12118.
10.
Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993;362:801–809.
11.
Chamley-Campbell J, Campbell GR, Ross R: The smooth muscle cell in culture. Physiol Rev 1979;59:1–61.
12.
Iivanainen A, Vuolteenaho R, Sainio K, Eddy R, Shows TB, Sariola H, Tryggvason K: The human laminin beta-2 chain (S-laminin): Structure, expression in fetal tissues and chromosomal assignment of the LAMB2 gene. Matrix Biol 1995;14:489–497.
13.
Glukhova M, Koteliansky V, Fondacci C, Marotte F, Rappaport L: Laminin variants and integrin laminin receptors in developing and adult human smooth muscle. Dev Biol 1993;157:437–447.
14.
Belkin VM, Belkin AM, Koteliansky VE: Human smooth muscle VLA-1 integrin: Purification, substrate specificity, localization in aorta, and expression during development. J Cell Biol 1990;111:2159–2170.
15.
Duband JL, Belkin AM, Syfrig J, Thiery JP, Koteliansky VE: Expression of alpha-1 integrin, a laminin-collagen receptor, during myogenesis and neurogenesis in the avian embryo. Development 1992;116:585–600.
16.
Mechtersheimer G, Barth T, Quentmeier A, Moller P: Differential expression of beta-1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells. Am J Pathol 1994;144:1172–1182.
17.
Hedin U, Bottger BA, Forsberg E, Johansson S, Thyberg J: Diverse effects of fibronectin and laminin on phenotypic properties of cultured arterial smooth muscle cells. J Cell Biol 1988;107:307–319.
18.
Hayashi K, Chimori Y, Saga H, Sobue K: IGF-I and laminin-generated signalings are essential for maintaining a differentiated phenotype of smooth muscle cells (submitted).
19.
Hu Y, Cgeng L, Hochleitner B-W, Xu Q: Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb 1997;17:2802–2816.
20.
Pyles JM, March KL, Franklin M, Mehdi K, Wilensky RL, Adam LP: Activation of MAP kinase in vivo follows balloon overstretch injury of porcine coronary and carotid arteries. Circ Res 1997;81:904–910.
21.
Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC: SB-203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stress and interleukin-1. FEBS Lett 1995;364:229–233.
22.
Vandekerckhove J, Weber K: At least six different actins are expressed in a higher mammal: An analysis based on the amino acid sequence of the amino-terminal tryptic peptide. J Mol Biol 1978;126:783–802.
23.
Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J Cell Biol 1986;103:2787–2796.
24.
Campbell JH, Kocher O, Skalli O, Gabbiani G, Campbell GR: Cytodifferentiation and expression of alpha-smooth muscle actin mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis 1989;9:633–643.
25.
Blank RS, McQuinn TC, Yin KC, Thompson MM, Takeyasu K, Schwartz RJ, Owens GK: Elements of the smooth muscle alpha-actin promoter required in cis for transcriptional activation in smooth muscle. Evidence for cell type-specific regulation. J Biol Chem 1992;267:984–989.
26.
Lazard D, Sastre X, Frid MG, Glukhova MA, Thiery JP, Koteliansky VE: Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue. Proc Natl Acad Sci USA 1993;90:999–1003.
27.
Johnson RJ, Iida H, Alpers CE, Majesky MW, Schwartz SM, Pritzi P, Gordon K, Gown AM: Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell profliferation. J Clin Invest 1991;87:847–858.
28.
Kirk TZ, Mark ME, Chua CC, Chua BH, Mayes MD: Myofibroblasts from scleroderma skin synthesize elevated levels of collagen and tissue inhibitor of metalloproteinase (TIMP-1) with two forms of TIMP-1. J Biol Chem 1995;270:3423–3428.
29.
Saga H, Kimura K, Hayashi K, Gotow T, Uchiyama Y, Momiyama T, Tadokoro S, Kawashima N, Jimbou A, Sobue K: Phenotype-dependent expression of α-smooth muscle actin in visceral smooth muscle cells (submitted).
30.
Kimura K, Saga H, Hayashi K, Obata H, Chimori Y, Ariga H, Sobue K: c-Myc gene single strand binding protein-1, MSSP-1, suppresses transcription of α-smooth muscle actin gene in chicken visceral smooth muscle cells. Nucleic Acids Res (in press).
31.
Yano H, Hayashi K, Momiyama T, Saga H, Haruna M, Sobue K: Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J Biol Chem 1995;270:23661–23666.
32.
Samaha FF, Ip HS, Morrisey EE, Seltzer J, Tang Z, Solway J, Parmacek MS: Developmental pattern of expression and genomic organization of the calponin-h1 gene. A contractile smooth muscle cell marker. J Biol Chem 1996;271:395–403.
33.
Miano JM, Oslon EN: Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis. J Biol Chem 1996;271:7095–7103.
34.
Lees-Miller JP, Heeley DH, Smillie LB: An abundant and novel protein of 22 kDA (SM22) is widely distributed in smooth muscles. Purification from bovine aorta. Biochem J 1987;244:705–709.
35.
Li L, Miano JM, Mercer B, Olson EN: Expression of the SM22alpha promoter in transgenic mice provides evidence for distinct transcriptional regulatory programs in vascular and visceral smooth muscle cells. J Cell Biol 1996;132:849–859.
36.
Kashiwada K, Nishida W, Hayashi K, Ozawa K, Yamanaka Y, Saga H, Yamashita T, Tohyama M, Shimada S, Sato K, Sobue K: Coordinate expression of alpha-tropomyosin and caldesmon isoforms in association with phenotypic modulation of smooth muscle cells. J Biol Chem 1997;272:15396–15404.
37.
Obata H, Hayashi K, Nishida W, Momiyama T, Sobue K: Smooth muscle cell phenotype-dependent transcriptional regulation of the alpha-1 integrin gene. J Biol Chem 1997;272:26648–26651.
38.
Katoh Y, Loukianov E, Kopras E, Zilberman A, Periasamy M: Identification of functional promoter elements in the rabbit smooth muscle myosin chain gene. J Biol Chem 1994;269:30538–30545.
39.
Moiseyeva EP, Weller PA, Zhidkova NI, Corben EB, Patel B, Jasinska I, Koteliansky VE, Critchley DR: Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter. J Biol Chem 1993;268:4318–4325.
40.
Zutter MM, Santoro SA, Painter AS, Tsung YL, Gafford A: The human alpha-2 integrin gene promoter. Identification of positive and negative regulatory elements important for cell-type and developmentally restricted gene expression. J Biol Chem 1994;269:463–469.
41.
Audet JF, Masson JY, Rosen GD, Salesse C, Guerin SL: Multiple regulatory elements control the basal promoter activity of the human alpha-4 integrin gene. DNA Cell Biol 1994;13:1071–1085.
42.
De Meirsman C, Schollen E, Jaspers M, Ongena K, Matthijs G, Marynen P, Cassiman JJ: Cloning and characterization of the promoter region of the murine alpha-4 integrin subunit. DNA Cell Biol 1994;13:743–754.
43.
Rosen GD, Birkenmeier TM, Dean DC: Characterization of the alpha-4 integrin gene promoter. Proc Natl Acad Sci USA 1991;88:4094–4098.
44.
Rosen GD, Barks JL, Iademarco MF, Fisher RJ, Dean DC: An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha-4 integrin gene promoter. J Biol Chem 1994;269:15652–15660.
45.
Nueda A, Lopez Cabrera M, Vara A, Corbi AL: Characterization of the CD11a (alpha-L, LFA-1 alpha) integrin gene promoter. J Biol Chem 1993;268:19305–19311.
46.
Lopez Cabrera M, Nueda A, Vara A, Garcia Aguilar J, Tugores A, Corbi AL: Characterization of the p150,95 leukocyte integrin alpha subunit (CD11c) gene promoter. Identification of cis-acting elements. J Biol Chem 1993;268:1187–1193.
47.
Madsen CS, Hershey JC, Hautmann MB, White SL, Owens GK: Expression of the smooth muscle myosin heavy chain gene is regulated by a negative-acting GC-rich element located between two positive-acting serum response factor-binding elements. J Biol Chem 1997;272:6332–6340.
48.
Kim S, Ip HS, Lu MM, Clendenin C, Parmacek MS: A serum response factor-dependent transcriptional regulatory program identifies distinct smooth muscle cell sublineage. Mol Cell Biol 1997;17:2266–2278.
49.
Nakamura M, Nishida W, Sobue K: Homeodomain protein Barx coactivates transcription of β-tropomyosin gene with serum response factor in the smooth muscle cells (submitted).
50.
Treisman R: Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5′ element and c-fos 3′ sequences. Cell 1985;42:889–902.
51.
Croissant JD, Kim J-H, Eichele G, Goering L, Lough J, Prywes R, Schwartz J: Avian serum response factor expression restricted primarily to muscle cell lineages is required for α-actin gene transcription. Dev Biol 1996;177:250–264.
52.
Gehring WJ, Affolter M, Burglin T: Homeodomain proteins. Annu Rev Biochem 1994;63:487–526.
53.
Gruenberg DA, Natesan S, Alexandre C, Gilman MZ: Human and Drosophila homeodomain proteins that enhance the DNA-binding activity of serum response factor. Science 1992;257:1089–1095.
54.
Gruenberg DA, Henry RW, Brauer A, Novina CD, Cheriyath V, Roy AL, Gilman M: A multifunctional DNA-binding protein that promotes the formation of serum response factor/homeodomain complexes: Identity to TFII-I. Genes Dev 1997;11:2482–2493.
55.
Chen CY, Schwartz RJ: Requirement of the tinman homolog Nkx-2.5 by serum response factor activates cardiac α-actin gene transcription. Mol Cell Biol 1996;16:6372–6384.
56.
Azpiazu N, Frasch M: Tinman and bagpipe: Two homeobox genes that determine cell fates in the dorsal mesoderm of Drosophila. Genes Dev 1993;7:1325–1340.
57.
Nishida W, Okada M, Yamanaka Y, Sobue K: Msx-1 is a critical marker for the myofibroblastosis (submitted).
58.
Robert B, Sassoon D, Jacq B, Gehring W, Buckingham M: Hox-7, a mouse homeobox gene with a novel pattern of expression during embryogenesis. EMBO J 1989;8:91–100.
59.
Davidson D: The function and evolution of Msx genes: Pointers and paradoxes. Trends Genet 1995;11:405–411.
60.
Owada MK, Hakura A, Iida K, Yahara I, Sobue K, Kakiuchi S: Occurrence of caldesmon (a calmodulin-binding protein) in cultured cells: Comparison of normal and transformed cells. Proc Natl Acad Sci USA 1984;81:3133–3137.
61.
Sobue K, Tanaka T, Kanda K, Ashino N, Kakiuchi S: Purification and characterization of caldesmon-77: A calmodulin-binding protein that interacts with actin filaments from bovine adrenal medulla. Proc Natl Acad Sci USA 1985;82:8025–5029.
62.
Ueki N, Sobue K, Kanda K, Hada T, Higashino K: Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 1987;84:9049–9053.
63.
Lees-Miller JP, Helfman DM: The molecular basis for tropomyosin isoform diversity. Bioessays 1991;13:429–437.
64.
Nagai R, Kuro-o M, Babij P, Periasamy M: Identification of two types of smooth muscle myosin heavy chain isoforms by cDNA cloning and immunoblot analysis. J Biol Chem 1989;264:9734–9737.
65.
Kuro-o M, Nagai R, Nakahara K, Katoh H, Tsai RC, Tsuchimochi H, Yazaki Y, Ohkubo A, Takaku F: cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem 1991;266:3768–3773.
66.
Kuro-o M, Nagai R, Tsuchimochi H, Katoh H, Yazaki Y, Ohkubo A, Takaku F: Developmentally regulated expression of vascular smooth muscle myosin heavy chain isoforms. J Biol Chem 1989;264:18272–18275.
67.
Glukhova MA, Kabakov AE, Frid MG, Ornatsky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE, Smirnov VN: Modulation of human aorta smooth muscle cell phenotype: A study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 1988;85:9542–9546.
68.
Moiseyeva EP, Weller PA, Zhidkova NI, Corben EB, Patel B, Jasinska I, Koteliansky VE, Critchley DR: Organization of the human gene encoding the cytoskeletal protein vinculin and the sequence of the vinculin promoter. J Biol Chem 1993;268:4318–4325.
69.
Humphrey MB, Bryan J, Cooper TA, Berget SM: A 32-nucleotide exon-splicing enhancer regulates usage of competing 5′ splice sites in a differential internal exon. Mol Cell Biol 1995;15:3979–3988.
70.
Helfman DM, Cheley S, Kuismanen E, Finn LA, Yamawaki-Kataoka Y: Nonmuscle and muscle tropomyosin insoforms are expressed from a single gene by alternative RNA splicing and polyadenylation. Mol Cell Biol 1986;6:3582–3595.
71.
Libri D, Lemonnier M, Meinnel T, Fiszman MY: A single gene codes for the beta subunits of smooth and skeletal muscle tropomyosin in the chicken. J Biol Chem 1989;264:2935–2944.
72.
Wieczorek DF, Smith CW, Nadal-Ginard B: The rat alpha-tropomyosin gene generates a minimum of six different mRNAs coding for striated, smooth, and nonmuscle isoforms by alternative splicing. Mol Cell Biol 1988;8:679–694.
73.
Lemonnier M, Balvay L, Mouly V, Libri D, Fiszman MY: The chicken gene encoding the alpha isoform of tropomyosin of fast-twitch muscle fibers: Organization, expression and identification of the major proteins synthesized. Gene 1991;107:229–240.
74.
Zamore PD, Patton JG, Green MR: Cloning and domain structure of the mammalian splicing factor U2AF. Nature 1992;355:609–614.
75.
Mullen MP, Smith CW, Patton JG, Nadal-Ginard B: Alpha-tropomyosin mutually exclusive exon selection: Competition between branchpoint/polypyrimidine tracts determines default exon choice. Genes Dev 1991;5:642–655.
76.
Herman IM, D’Amore PA: Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 1985;101:43–52.
77.
Adler KB, Craighead JE, Vallyathan NV, Evans JN: Actin-containing cells in human pulmonary fibrosis. Am J Pathol 1981;102:427–437.
78.
Schmitt-Graff A, Kruger S, Bochard F, Gabbiani G, Denk H: Modulation of alpha smooth muscle actin and desmin expression in perisinusoidal cells of normal and diseased human livers. Am J Pathol 1991;138:1233–1242.
79.
Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of ‘muscle-specific’ actin in glomerulonephritis. Kidney Int 1992;41:1134–1142.
80.
Ramadori G, Veit T, Schwogler S, Dienes HP, Knittel T, Rieder H, Meyer zum Buschenfelde KH: Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells. Virchows Arch B 1990;59:349–357.
81.
Ando Y, Moriyama T, Miyazaki M, Akagi Y, Kawada N, Isaka Y, Izumi M, Yokoyama K, Yamauchi A, Horio M, Ando A, Udea N, Sobue K, Imai E, Hori M: Enhanced glomerular expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy. Nephrol Dial Transplant (in press).
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.